April 5, 2004
Hall said, "Theoretically at least, there's more of a potential for the spread of infection than you would have if you were more aggressive about treating this population." Dr. David Bangsberg, senior author of the study, associate professor at UCSF and director of San Francisco General's Epidemiology and Prevention Interventions Center, said that the results indicate a "longtime indifference to chronic liver disease in the poorest of the urban poor," according to the Chronicle. He said that the hospital has begun to address the problem of HIV-hepatitis C coinfection, but he added that it is "too soon" to see results "on the streets," the Chronicle reports. According to Bangsberg, "One of the broader issues here is that this city has done a great job making sure everyone, regardless of housing status and income, is getting high-quality care for HIV. The city has not done the same in making sure there's access to treatment" for hepatitis C (Hall, San Francisco Chronicle, 4/2).
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|No Increased Risk of Liver Cancer After Hepatitis C Treatment With Direct-Acting Antivirals|
|This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue|
|This Week in HIV Research: HIV-Related Inflammation May Be Irreversible; and Genetically Engineered T-Cells Resist HIV|
|How Close Are We to a Cure for HIV? A Q&A With HIV Cure Scientific Superstars|
|Dolutegravir and the Central Nervous System: A Top HIV Clinical Development of 2016|